Head and Neck Squamous Cell Carcinoma Clinical Trials in Guangzhou, Guangdong
13 recruitingGuangzhou, Guangdong, China
Showing 1–13 of 13 trials
Recruiting
Not Applicable
Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma
Qunxing Li,MD60 enrolled1 locationNCT07369882
Recruiting
Not Applicable
Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Sun Yat-sen University50 enrolled1 locationNCT06630780
Recruiting
Phase 2
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
Head and Neck Squamous Cell Carcinoma
Guangdong Provincial People's Hospital86 enrolled1 locationNCT05272696
Recruiting
Phase 2
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma (HNSCC)HNSCC
Sun Yat-sen University24 enrolled2 locationsNCT06673693
Recruiting
Not Applicable
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
Sentinel Lymph NodeHead and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University70 enrolled1 locationNCT05437380
Recruiting
The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University100 enrolled1 locationNCT06727162
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 2
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma
Lyvgen Biopharma Holdings Limited64 enrolled17 locationsNCT06378177
Recruiting
Phase 2
Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC
Head and Neck Squamous Cell CarcinomaOral Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University100 enrolled1 locationNCT05941338
Recruiting
Phase 2
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University57 enrolled1 locationNCT04807140
Recruiting
Phase 2
A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
Head and Neck Squamous Cell Carcinomas
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University41 enrolled2 locationsNCT04992559
Recruiting
Phase 3
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University220 enrolled1 locationNCT05044117
Recruiting
Phase 2
Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC
Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University53 enrolled1 locationNCT04826679